New York, New York (PRWEB) April 26, 2013
Malecare Prostate Cancer Support will present a teleconference titled, "Understanding the New Options for Men with Advanced Prostate Cancer – Treatments, Immunotherapy & Clinical Trials." The conference is scheduled for Tuesday, April 30, 2013 at 6PM EDT. The teleconference is available without cost and open to public participation. Simply dial in at 800-920-7487 or direct dial 404 920 1710 Conference code 8534374.
Topics to be covered:
1- An overview of the new treatments now available for men with castrate resistant advanced prostate including a discussion of the sequencing and combining of these treatments.
2- A discussion about immunotherapies and their role in current treatment.
This teleconference is appropriate for all men diagnosed with prostate cancer, their family, friends and allies. Please email your questions for the speakers, in advance, to info(at)malecare(dot)org
James L. Gulley, M.D., Ph.D., F.A.C.P.
Director, Clinical Trials Group &
Deputy Chief, Laboratory of Tumor Immunology and Biology
Senior Investigator, Medical Oncology Branch
Center for Cancer Research, National Cancer Institute National Institutes of Health
Joel Nowak, MSW, MS
Director, Advocacy and Advanced Stage Disease
Malecare Cancer Support
Founded in 1998, Malecare is America's largest prostate cancer support group and patient advocacy nonprofit organization. More information about Malecare and it's services can be found at http://www.malecare.org